Enrique Conterno Archives - CDR

Eli Lilly to offer insulin discounts via Blink Health

December 13, 2016 by Chain Drug Review Blink Health, Blink Health Insulin Patient Access Program, Eli Lilly, Enrique Conterno, Express Scripts, Geoffrey Chaiken, Lilly Diabetes, Lilly insulin, Mike Mason Leading Headlines, Pharmacy, Supplier News, Technology

INDIANAPOLIS — Eli Lilly and Co. has partnered with Express Scripts to enable diabetes patients to access discounts for Lilly insulin products through digital drug search and pricing service Blink Health. Lilly said Tuesday that the discounted prices for its insulin are slated to become available on Jan. 1 through Blink Health mobile and web

Jardiance approved to cut cardiovascular death risk

December 6, 2016 by Chain Drug Review Boehringer Ingelheim, Boehringer Ingelheim and Lilly diabetes alliance, Eli Lilly, empagliflozin, Enrique Conterno, Jardiance, Lilly Diabetes, Paul Fonteyne, risk of cardiovascular death, type 2 diabetes treatment Pharmacy, Supplier News

RIDGEFIELD, Conn., and INDIANAPOLIS — Jardiance tablets, marketed by Boehringer Ingelheim and Eli Lilly and Co., have been approved by the Food and Drug Administration to cut the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. BI and Lilly said the FDA clearance makes Jardiance (empagliflozin) the first type